- 18 Oct 2020
The tests will be conducted on voluntary basis. As per the World Health Organization, estimate says that no more than 2% to 3% of the world population have antibodies that can suggest if they were previously infected. The antibody was found to attack the virus in a monoclonal way and can neutralize it within the bodies of those ill.
Health Ministry director general of Israel, Moshe Bar Siman-Tov said that from firms in the countries like United States and Italy, 100,000 serological test kits have been obtained from for a deal of $40 million. All health clinics across the country in the coming weeks are being prepared for the same.
Israel is not behaving like the Ignorant guardian for its citizens and has already started preparing for the second wave of COVID-19. The tests will be conducted on voluntary basis. This is just a survey done by Israel to understand the percentage of its population who have developed antibodies against the Novel Corona virus. Once tested positive for antibodies, they will be sent for follow-up testing.
As per the World Health Organization, estimate says that no more than 2% to 3% of the world population have antibodies that can suggest if they were previously infected. So, serological testing can be just taken for surveying and cannot be made the hallmark of actual testing.
“This is the most important mission: Get ready for the next wave, especially a wave during wintertime. Luckily, the COVID-19 caught us post-influenza season. But we can’t assume that there’s not going to be a next wave or that it will be during summertime,” Bar Siman-Tov said.
As per the World Health Organization, it is estimated that no more than 2% to 3% of the world population have antibodies that demonstrate whether they were previously infected. So, serological testing can be just taken for surveying and not be made the hallmark of final testing.
Earlier, Israel’s defense minister Naftali Bennet announced that the Israel’s Institute of Biological Research (IIBR) has made a “significant breakthrough” in developing an antibody for the novel corona virus. He said that the antibody is past its development phase and now they are ready to patent and mass produce the treatment.
According to his office, Mr.Bennett, supervised by the Prime minister’s office, visited the labs of the IIBR to advice for the development of vaccine for corona virus. The antibody was found to attack the virus in a monoclonal way and can neutralize it within the bodies of those ill.
The office also said that the development of the antibody is completed and the institute is in the way to patenting the finding. The next stage will be to approach international companies by the researchers to produce the antibody on a commercial scale.
It is not clear if the report presented to Bennet is in addition to the progress which was reported in late March. It is also yet not known whether the antibody has been tried on human samples. Even the success of serological testing has not yet seen much cheer. Whatever may be the case, the small Jewish nation, by its leading research institutions, renowned scientists and an open culture towards innovation, is leading the way forward for the world to follow.